Evidence map›Paper›PMID 31674304›Full record

ReviewPreventing chronic disease2019

Global Surveillance of trans-Fatty Acids.

Chaoyang Li, Laura K Cobb, Hubert W Vesper, Samira Asma

Open access · diamondAbstract readReview
In one paragraph

Review in Preventing chronic disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Nutrients · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Validity and reproducibility of the intake ofThe British journal of nutrition · 2023
    Article
  12. Amelioration of oxidative kidney damage in offspring by maternal trans-fatty acid exposure in mice by secoisolariciresinol diglucoside.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  13. Article
  14. Article
  15. Nutrients · 2022
    Article
  16. Article
  17. Evaluating progress and addressing actions to eliminate industrially produced trans-fatty acids in the Americas.Revista panamericana de salud publica = Pan American journal of public health · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Chaoyang LiDivision of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, 1825 Century Blvd, Atlanta, GA 30345. Email: cli@cdc.gov.
Laura K CobbResolve to Save Lives, Vital Strategies, New York, New York.
Hubert W VesperDivision of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
Samira AsmaWorld Health Organization, Geneva, Switzerland.
Centers for Disease Control and Prevention · USVital Strategies · USWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

Trans-fatty acid (TFA) intake can increase the risk of coronary heart disease (CHD) morbidity and mortality and all-cause mortality. Industrially produced TFAs and ruminant TFAs are the major sources in foods. TFA intake and TFA-attributed CHD mortality vary widely worldwide. Excessive TFA intake is a health threat in high-income countries; however, it is also a threat in low- and middle-income countries (LMICs). Data on TFA intake are scarce in many LMICs and an urgent need exists to monitor TFAs globally. We reviewed global TFA intake and TFA-attributed CHD mortality and current progress toward policy or regulation on elimination of industrially produced TFAs in foods worldwide. Human biological tissues can be used as biomarkers of TFAs because they reflect actual intake from various foods. Measuring blood TFA levels is a direct and reliable method to quantify TFA intake.

Indexed as

Chronic DiseaseCoronary DiseaseGlobal HealthHealth PolicyHumansRisk FactorsTrans Fatty AcidsTrans Fatty Acids

Identifiers

PMID31674304
PMCPMC6880923
OpenAlexW2981694886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.